Welcome to Dementias Platform UK

Detection. Treatment. Prevention.

Save the date for DPUK's new translational dementia research conference

DPUK is delighted to announce Translation 2023 – a new, cross-sector translational dementia research conference. It will take place from 2-3 March at BMA House, London.

What are biomarkers and why are they important in dementia research?

In this blog post, we explore how researchers can use biomarkers to see dementia-related changes in the brain, track disease onset and progression, and test treatments.

We did it! Team DPUK hikes 26 miles for dementia research

On Saturday 24 September 2022, five members of team DPUK hiked 26 miles in the Peak District to raise money for Alzheimer's Research UK.

Early-career focus: Melek Karadag-Assem

On World Alzheimer’s Day 2022, we spoke to dementia researcher Melek Karadag-Assem about her work on the DPUK-funded NTAD and SHINE brain imaging studies.

Digital healthcare company Five Lives joins DPUK consortium as industry partner

DPUK is delighted to welcome the health technology company Five Lives as its newest industry partner.

Reaction: UK government confirms major new funding for dementia research

The UK government has announced the launch of a ‘national mission’ to tackle dementia, pledging again to double research funding to £160m per year by 2024.

A scientist takes a vial of blood from a selection of blood test samples

Diadem partners with DPUK to advance Alzheimer’s diagnosis and treatment

Diadem SpA, a company developing AlzoSure Predict, the first blood-based test for the early prediction of progression to Alzheimer’s disease, has joined DPUK as an industry partner.

Screengrab of the dementia data landscape report

New report signposts global dementia data assets for benefit of researchers

Dementias Platform UK (DPUK) today launches its new ‘Data Landscape Report’ – the most comprehensive overview to date of available dementia data assets worldwide.

About DPUK

DPUK brings together the best scientific minds and global leaders in the pharmaceutical industry to find new ways of detecting, treating and preventing dementia.

Our data-driven platform gives scientists fast access to findings, technology and volunteers – powering research to stop dementia in its tracks.

More about DPUK

Tweets by DementiasUK

Our research

Stylised image of the world featuring connecting dots

The DPUK Data Portal gives researchers rapid, secure access to millions of health research records.

More about the Data Portal

A group of older people smiling after exercising

Our Trials Delivery Framework matches public volunteers to the right dementia studies.

More about the TDF

Our Experimental Medicine Incubator accelerates and de-risks the development of new treatments.

More about the EMI

Research highlights

Stylised image of a DNA double helix using water droplets

Featured research: Can our genes predict our likelihood of developing dementia?

A project led by researchers at Cardiff University is analysing data in the DPUK Data Portal to predict genetic risk of dementia, focusing on genes related to the brain's immune system.

Find out more

Featured researcher: Dr Ivan Koychev

Dr Ivan Koychev is senior clinical researcher at DPUK and leads our research volunteer registry. Dr Koychev is running a new clinical trial examining whether a drug used for the treatment of diabetes could also reduce the risk of Alzheimer's disease.

Find out more

Work with us

Would you like to increase the international visibility of your data? Try our Data Portal.

Do you need well-characterised volunteers for your early-phase trial? Use our Trials Delivery Framework.

Is there a mechanism you would like to investigate? Explore our Experimental Medicine Incubator.

Contact DPUK